Navigation Links
Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline
Date:12/27/2019

Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline that offers patients and healthcare providers options in the treatment of chronic diseases that disproportionately affect geriatric patients. The products concepts were identified in collaboration with doctors and managed care professionals and developed at Vici’s R&D facility in Maryland. Vici has completed first round of communication with FDA and is currently working on scaling up the manufacturing process in anticipation of entering the registration phase of the project. Simultaneously Vici is in talks with its commercialization partners to ensure that doctors and patients have full access to these products that will significantly help improve patient outcomes.

About Vici Health Sciences LLC
Vici Health Sciences (Vici) is a U.S. based pharmaceutical research and development company. Vici is focused on specialty branded and generic pharmaceutical product development and commercialization. Vici’s goal is to improve clinical outcomes, enhance access, and reduce costs for patients and healthcare providers.

Read the full story at https://www.prweb.com/releases/vici_health_sciences_is_announcing_its_successful_completion_of_initial_clinical_studies_for_its_505b2_product_pipeline/prweb16807389.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Focal Healthcare’s Fusion Bx 2.0 Targeted Prostate Biopsy Solution Receives CE Mark
2. Leading Experiential Marketing Agency, Sparks, Invests in Healthcare Marketing Firm, Bichsel Medical Marketing Group
3. Tech PR Firm ARPR Honored as a Health Care PR Agency of the Year; Grows HealthIT Practice Group 18% Quarter-Over-Quarter
4. BHIP Takes Aim at Teenagers’ Stress, Anxiety, Executive Function, Interpersonal Skills, and Overall Mental Health
5. eKare’s inSight Joins the NHS Digital Health Accelerator Program
6. Advancements Announces New Episode Focusing on Innovations in Health, Medicine, and Technology
7. MyBioGate Global Healthcare Innovation Competition Boston Preliminary Successfully Came to the Conclusion
8. Visikol Presents on Imaging 3D Cell Culture Models at the National Institute of Health
9. VetStem Biopharma, Parent Company of Personalized Stem Cells, is Approved for Stem Cell Manufacturing by the California Department of Public Health
10. Centura Health’s Innovative Patient Experience Initiative for Needle-Free Blood Draws
11. uBiome Awards Grant to North Carolina A&T State University to Study Gut Microbiome and Cardiovascular Health Risks in African-American Athletes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2020)... ... February 03, 2020 , ... Ovation Travel Group ... Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. , All of the ... following statistics:, Average airfare price paid Domestically, Internationally ...
(Date:1/28/2020)... FORT WORTH, Texas (PRWEB) , ... January 28, ... ... Midland Scientific to be the exclusive distributor to food and beverage manufactures ... years and are considered critical suppliers. This agreement will allow each company to ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an addition ... Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment ... can extend the accuracy and ease of use of salivary bioscience into infectious ...
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the leading innovator in ... led by Halma plc , a FTSE 100 global group of life-saving ... and WSJ Joshua Fund. A representative from Halma will join the Valencell board ...
Breaking Biology Technology:
(Date:1/28/2020)... ... January 28, 2020 , ... Blue ... efficiency, reduce total cost of care, and limit the utilization of high-cost imaging ... group headquartered in San Antonio, Texas specializes in improving care delivery for MSK ...
(Date:1/27/2020)... ... 27, 2020 , ... Cytonus Therapeutics Inc. today announced the ... and former senior management consultant at McKinsey & Company who holds three Harvard ... firm. , “Chris Thorne has exceptional business acumen with a proven track ...
(Date:1/24/2020)... ... January 24, 2020 , ... ... to mobilize Colorado’s capital resources to support early-stage bioscience companies in the state. ... startups have struggled to find the funding they need to innovate and grow. ...
Breaking Biology News(10 mins):